Additional Laboratory Testing for Iron Overload and Metabolic Liver Disease
This patient requires transferrin saturation and total iron-binding capacity (TIBC) testing immediately to evaluate for hereditary hemochromatosis, along with a standard liver aetiology screen including hepatitis B surface antigen, hepatitis C antibody, anti-mitochondrial antibody, anti-smooth muscle antibody, antinuclear antibody, serum immunoglobulins, and abdominal ultrasound. 1
Immediate Priority: Iron Overload Assessment
The combination of elevated ferritin (332 ng/mL) and high serum iron (179 mcg/dL) in a young woman raises significant concern for hereditary hemochromatosis or other iron overload disorders. 2, 3
- Calculate transferrin saturation: This is the critical first step, as females with transferrin saturation >45% and ferritin >200 μg/L warrant genetic testing for HFE mutations (specifically p.C282Y). 2
- Transferrin saturation >60% with ferritin levels predict clinically significant liver iron content (>7 mg/g dry weight) with 95% accuracy and would indicate need for liver MRI quantification or more aggressive evaluation. 4
- If transferrin saturation is elevated, proceed with HFE genotyping for p.C282Y and p.H63D mutations after obtaining informed consent. 2
Standard Liver Aetiology Screen
Given the mildly elevated ALT (44 U/L) and total bilirubin (1.6 mg/dL), a comprehensive workup is mandatory regardless of the degree of abnormality. 1
Required testing includes: 1
- Hepatitis B surface antigen
- Hepatitis C antibody (with reflex PCR if positive)
- Anti-mitochondrial antibody
- Anti-smooth muscle antibody
- Antinuclear antibody
- Serum immunoglobulins
- Abdominal ultrasound
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Evaluation
The borderline elevated triglycerides (173 mg/dL) combined with mildly elevated ALT suggests possible MASLD, the most common cause of mild transaminase elevation affecting up to 30% of the population. 3, 5
Additional metabolic testing needed: 3
- Fasting glucose
- Complete lipid profile (if not already done)
- Complete blood count with platelets
Risk stratification for fibrosis: 1
- Calculate FIB-4 Index Score or NAFLD Fibrosis Score to determine if the patient has significant fibrosis risk requiring hepatology referral
- FIB-4 uses age, AST, ALT, and platelet count
- This is first-line testing for MASLD patients to assess fibrosis extent 1
Important Clinical Context
The ALT of 44 U/L may actually represent significant elevation in a young woman, as updated reference intervals suggest the upper limit of normal for females should be 22 U/L when using metabolically and histologically healthy populations. 6 This means her ALT is approximately twice the true normal upper limit.
Regarding the elevated bilirubin (1.6 mg/dL):
- Fractionate the bilirubin into direct (conjugated) and indirect (unconjugated) components. 7, 8
- Conjugated hyperbilirubinemia suggests hepatocellular damage or cholestasis
- Unconjugated hyperbilirubinemia may indicate hemolysis or Gilbert syndrome 8
- The combination of elevated bilirubin with iron overload can indicate advanced hemochromatosis with hepatocellular dysfunction 9
Critical Pitfalls to Avoid
- Do not dismiss the iron parameters as "mildly elevated": Hemochromatosis in women often presents later and with less obvious biochemical abnormalities than in men, but can still cause significant organ damage. 2
- Do not wait for symptoms to progress: Hereditary hemochromatosis requires early detection and treatment to prevent cirrhosis, diabetes, cardiomyopathy, and arthropathy. 2
- Avoid alcohol consumption: Even small amounts should be discouraged in the presence of iron overload and liver abnormalities, as alcohol dramatically increases risk of progression. 2
- Do not order hepcidin levels: This is not recommended for hemochromatosis diagnosis. 2
If Initial Workup is Negative
Should the standard liver aetiology screen return normal, consider testing for less common causes: 5, 7
- Alpha-1-antitrypsin level
- Ceruloplasmin (for Wilson disease, though less likely at age 33)
- Celiac antibodies
- Thyroid function tests